Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Sepsis

  Free Subscription


Articles published in Intensive Care Med

Retrieve available abstracts of 76 articles:
HTML format



Single Articles


    January 2024
  1. PROWLE JR, Bagshaw SM, Forni LG
    Tackling sepsis-associated AKI: are there any chances of REVIVAL with new approaches?
    Intensive Care Med. 2024 Jan 10. doi: 10.1007/s00134-023-07294.
    PubMed    


  2. PICKKERS P, Angus DC, Bass K, Bellomo R, et al
    Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL).
    Intensive Care Med. 2024 Jan 3. doi: 10.1007/s00134-023-07271.
    PubMed     Abstract available


  3. ZAMPIERI FG, Machado FR, Veiga VC, Azevedo LCP, et al
    Determinants of fluid use and the association between volume of fluid used and effect of balanced solutions on mortality in critically ill patients: a secondary analysis of the BaSICS trial.
    Intensive Care Med. 2024;50:79-89.
    PubMed     Abstract available


    November 2023
  4. BALIK M, Maly M, Brozek T, Rulisek J, et al
    Propafenone versus amiodarone for supraventricular arrhythmias in septic shock: a randomised controlled trial.
    Intensive Care Med. 2023;49:1283-1292.
    PubMed     Abstract available


    October 2023
  5. FOWLER C, Scordo M, Chawla S
    The EAS(E)IX of predicting sepsis after allogeneic hematopoietic cell transplantation.
    Intensive Care Med. 2023 Oct 24. doi: 10.1007/s00134-023-07242.
    PubMed    


  6. VAN AMSTEL RBE, Kennedy JN, Scicluna BP, Bos LDJ, et al
    Uncovering heterogeneity in sepsis: a comparative analysis of subphenotypes.
    Intensive Care Med. 2023 Oct 18. doi: 10.1007/s00134-023-07239.
    PubMed     Abstract available


  7. ZHANG Z, Chen L, Liu X, Yang J, et al
    Exploring disease axes as an alternative to distinct clusters for characterizing sepsis heterogeneity.
    Intensive Care Med. 2023 Oct 4. doi: 10.1007/s00134-023-07226.
    PubMed     Abstract available


    September 2023
  8. WHITE KC, Laupland KB, Tabah A, Ramanan M, et al
    Details and the devil within: the case of sepsis associated AKI. Author's reply.
    Intensive Care Med. 2023 Sep 10. doi: 10.1007/s00134-023-07209.
    PubMed    


    August 2023
  9. GOMEZ H, Zarbock A
    Details and the devil within - the case of sepsis associated acute kidney injury.
    Intensive Care Med. 2023 Aug 31. doi: 10.1007/s00134-023-07204.
    PubMed    


  10. WHITE KC, Laupland KB, Tabah A, Ramanan M, et al
    Clinical implications of urine output-based sepsis-associated acute kidney injury. Author's reply.
    Intensive Care Med. 2023 Aug 28. doi: 10.1007/s00134-023-07205.
    PubMed    


  11. CLAURE-DEL GRANADO R, James MT, Legrand M
    Tackling sepsis-associated acute kidney injury using routinely collected data.
    Intensive Care Med. 2023 Aug 28. doi: 10.1007/s00134-023-07200.
    PubMed    


  12. GIAMARELLOS-BOURBOULIS EJ, Zinkernagel AS, De Robertis E, Azoulay E, et al
    Correction: Sepsis, a call for inclusion in the work plan of the European Center for Disease Prevention and Control.
    Intensive Care Med. 2023 Aug 24. doi: 10.1007/s00134-023-07197.
    PubMed    


  13. KORELL F, DeFilipp Z, Schreck N, Luft T, et al
    Validation of pre-conditioning EASIX for prediction of sepsis after allogeneic stem cell transplantation.
    Intensive Care Med. 2023 Aug 23. doi: 10.1007/s00134-023-07193.
    PubMed    


  14. KASUGAI D, Nakashima T, Goto T
    Clinical implications of urine output-based sepsis-associated acute kidney injury.
    Intensive Care Med. 2023 Aug 21. doi: 10.1007/s00134-023-07190.
    PubMed    


  15. GIAMARELLOS-BOURBOULIS EJ, Zinkernagel AS, De Robertis E, Azoulay E, et al
    Sepsis, a call for inclusion in the work plan of the European Center for Disease Prevention and Control.
    Intensive Care Med. 2023 Aug 1. doi: 10.1007/s00134-023-07127.
    PubMed    


    July 2023
  16. REILLY JP, Zhao Z, Shashaty MGS, Koyama T, et al
    Exposure to ambient air pollutants and acute respiratory distress syndrome risk in sepsis.
    Intensive Care Med. 2023 Jul 20. doi: 10.1007/s00134-023-07148.
    PubMed     Abstract available


  17. WHITE KC, Serpa-Neto A, Hurford R, Clement P, et al
    Sepsis-associated acute kidney injury in the intensive care unit: incidence, patient characteristics, timing, trajectory, treatment, and associated outcomes. A multicenter, observational study.
    Intensive Care Med. 2023 Jul 11. doi: 10.1007/s00134-023-07138.
    PubMed     Abstract available


  18. KJAER MN, Meyhoff TS, Sivapalan P, Granholm A, et al
    Long-term effects of restriction of intravenous fluid in adult ICU patients with septic shock.
    Intensive Care Med. 2023;49:820-830.
    PubMed     Abstract available


    June 2023
  19. ZHANG C, Zhang X, Sun Z, Liu X, et al
    MetaSepsisBase: a biomarker database for systems biological analysis and personalized diagnosis of heterogeneous human sepsis.
    Intensive Care Med. 2023 Jun 17. doi: 10.1007/s00134-023-07126.
    PubMed    


  20. BRUNO RR, Wollborn J, Fengler K, Flick M, et al
    Direct assessment of microcirculation in shock: a randomized-controlled multicenter study.
    Intensive Care Med. 2023;49:645-655.
    PubMed     Abstract available


    April 2023
  21. BOLDT J, Muller M, Kuhn D, Linke LC, et al
    Retraction Note: Circulating adhesion molecules in the critically ill: A comparison between trauma and sepsis patients.
    Intensive Care Med. 2023 Apr 4. doi: 10.1007/s00134-023-07055.
    PubMed    


    February 2023
  22. MATCHETT G, Moon TS, Stewart JW, Liang L, et al
    Etomidate for endotracheal intubation in sepsis. Author's reply.
    Intensive Care Med. 2023 Feb 23. doi: 10.1007/s00134-023-06987.
    PubMed    


  23. TABAH A, Buetti N, Staiquly Q, Ruckly S, et al
    Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study.
    Intensive Care Med. 2023 Feb 10:1-13. doi: 10.1007/s00134-022-06944.
    PubMed     Abstract available


    January 2023
  24. KALIMOUTTOU A, Pirracchio R
    Database-based machine learning in sepsis deserves attention. Author's reply.
    Intensive Care Med. 2023 Jan 10. doi: 10.1007/s00134-022-06972.
    PubMed    


  25. MOHR NM, Faine B
    Etomidate for endotracheal intubation in sepsis.
    Intensive Care Med. 2023 Jan 4. doi: 10.1007/s00134-022-06962.
    PubMed    


  26. HU W, Yang M, Chen H
    Database-based machine learning in sepsis deserves attention.
    Intensive Care Med. 2023 Jan 2. doi: 10.1007/s00134-022-06961.
    PubMed    


  27. POVOA P, Coelho L, Dal-Pizzol F, Ferrer R, et al
    How to use biomarkers of infection or sepsis at the bedside: guide to clinicians.
    Intensive Care Med. 2023 Jan 2:1-12. doi: 10.1007/s00134-022-06956.
    PubMed     Abstract available


    November 2022
  28. KALIMOUTTOU A, Lerner I, Cheurfa C, Jannot AS, et al
    Machine-learning-derived sepsis bundle of care.
    Intensive Care Med. 2022 Nov 29. doi: 10.1007/s00134-022-06928.
    PubMed     Abstract available


  29. DE PASCALE G, Antonelli M, Deschepper M, Arvaniti K, et al
    Poor timing and failure of source control are risk factors for mortality in critically ill patients with secondary peritonitis.
    Intensive Care Med. 2022;48:1593-1606.
    PubMed     Abstract available


    September 2022
  30. BHAVANI SV, Semler M, Qian ET, Verhoef PA, et al
    Development and validation of novel sepsis subphenotypes using trajectories of vital signs.
    Intensive Care Med. 2022 Sep 24. pii: 10.1007/s00134-022-06890.
    PubMed     Abstract available


  31. COUR M, Klouche K, Souweine B, Quenot JP, et al
    Remote ischemic conditioning in septic shock: the RECO-Sepsis randomized clinical trial.
    Intensive Care Med. 2022 Sep 14. pii: 10.1007/s00134-022-06872.
    PubMed     Abstract available


  32. RUSSELL JA, Meyer NJ, Walley KR
    Use of Mendelian randomization to better understand and treat sepsis.
    Intensive Care Med. 2022 Sep 14. pii: 10.1007/s00134-022-06778.
    PubMed    


  33. DE WAELE JJ, Girardis M, Martin-Loeches I
    Source control in the management of sepsis and septic shock.
    Intensive Care Med. 2022 Sep 14. pii: 10.1007/s00134-022-06852.
    PubMed    


    August 2022
  34. YOUNG PJ, Lamontagne F, Fujii T
    Vitamin C in sepsis.
    Intensive Care Med. 2022 Aug 12. pii: 10.1007/s00134-022-06822.
    PubMed    


    July 2022
  35. LUKASZEWSKI RA, Jones HE, Gersuk VH, Russell P, et al
    Presymptomatic diagnosis of postoperative infection and sepsis using gene expression signatures.
    Intensive Care Med. 2022 Jul 13. pii: 10.1007/s00134-022-06769.
    PubMed     Abstract available


    June 2022
  36. BLOOS F, Held J, Kluge S, Simon P, et al
    (1 --> 3)-beta-D-Glucan-guided antifungal therapy in adults with sepsis: the CandiSep randomized clinical trial.
    Intensive Care Med. 2022 Jun 16. pii: 10.1007/s00134-022-06733.
    PubMed     Abstract available


  37. MEYNAAR IA, van Rijn S, Ottens TH, van Burgel ND, et al
    Increased risk of central line-associated bloodstream infection in COVID-19 patients associated with dexamethasone but not with interleukin antagonists.
    Intensive Care Med. 2022 Jun 7. pii: 10.1007/s00134-022-06750.
    PubMed    


    April 2022
  38. KORELL F, Schreck N, Muller-Tidow C, Dreger P, et al
    Pre-transplant EASIX and sepsis after allogeneic stem cell transplantation.
    Intensive Care Med. 2022 Apr 16. pii: 10.1007/s00134-022-06676.
    PubMed    


  39. TRAN A, Fernando SM, Rochwerg B, Seymour CW, et al
    Characterizing systematic challenges in sample size determination for sepsis trials.
    Intensive Care Med. 2022 Apr 12. pii: 10.1007/s00134-022-06691.
    PubMed    


  40. POOLE D, D'Arrigo S
    Coupled plasma filtration and adsorption for the treatment of septic shock.
    Intensive Care Med. 2022;48:493-495.
    PubMed    


    March 2022
  41. BUIL JB, Schouten JA, Wauters J, van de Hoeven H, et al
    Absence of candidemia in critically ill patients with COVID-19 receiving selective digestive decontamination.
    Intensive Care Med. 2022 Mar 22. pii: 10.1007/s00134-022-06651.
    PubMed    


  42. HAGEL S, Bach F, Brenner T, Bracht H, et al
    Correction to: Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial.
    Intensive Care Med. 2022 Mar 18. pii: 10.1007/s00134-022-06668.
    PubMed    


  43. GIJSEN M, Dreesen E, Wauters J, Debaveye Y, et al
    The TARGET trial as a plea for model-informed precision dosing of piperacillin/tazobactam in patients with sepsis.
    Intensive Care Med. 2022 Mar 17. pii: 10.1007/s00134-022-06679.
    PubMed    


  44. HAGEL S, Pletz MW, Lehmann T
    Concerns about study design and suggestion of additional analysis of therapeutic drug monitoring-guided piperacillin/tazobactam therapy for patients with sepsis. Author's reply.
    Intensive Care Med. 2022 Mar 15. pii: 10.1007/s00134-022-06669.
    PubMed    


    February 2022
  45. YOSHIHIRO S, Taito S
    Concerns about study design and suggestion of additional analysis of therapeutic drug monitoring-guided piperacillin/tazobactam therapy for patients with sepsis.
    Intensive Care Med. 2022 Feb 18. pii: 10.1007/s00134-022-06648.
    PubMed    


  46. ZHANG S, Li B, Yi S, He Z, et al
    Goal-directed therapy in sepsis strikes back. Author's reply.
    Intensive Care Med. 2022 Feb 14. pii: 10.1007/s00134-022-06633.
    PubMed    


  47. ANGRIMAN F, Rosella LC, Lawler PR, Ko DT, et al
    Sepsis hospitalization and risk of subsequent cardiovascular events in adults: a population-based matched cohort study.
    Intensive Care Med. 2022 Feb 10. pii: 10.1007/s00134-022-06634.
    PubMed     Abstract available


  48. HAGEL S, Bach F, Brenner T, Bracht H, et al
    Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial.
    Intensive Care Med. 2022 Feb 1. pii: 10.1007/s00134-021-06609.
    PubMed     Abstract available


  49. BAKKER J, Kattan E, Annane D, Castro R, et al
    Current practice and evolving concepts in septic shock resuscitation.
    Intensive Care Med. 2022;48:148-163.
    PubMed     Abstract available


    January 2022
  50. CHEN HH, Lin CH, Wu CL, Chao WC, et al
    Incidence and risk factors of mental illness among the spouses of patients with sepsis: a population-based cohort study.
    Intensive Care Med. 2022 Jan 25. pii: 10.1007/s00134-022-06624.
    PubMed    


  51. YU K, Zhang S, Chen N, Chen M, et al
    Critical care ultrasound goal-directed versus early goal-directed therapy in septic shock.
    Intensive Care Med. 2022;48:121-123.
    PubMed    


    December 2021
  52. PETERS-SENGERS H, Butler JM, Uhel F, Schultz MJ, et al
    Source-specific host response and outcomes in critically ill patients with sepsis: a prospective cohort study.
    Intensive Care Med. 2021 Dec 13. pii: 10.1007/s00134-021-06574.
    PubMed     Abstract available


    November 2021
  53. FUJII T, Salanti G, Belletti A, Bellomo R, et al
    Effect of adjunctive vitamin C, glucocorticoids, and vitamin B1 on longer-term mortality in adults with sepsis or septic shock: a systematic review and a component network meta-analysis.
    Intensive Care Med. 2021 Nov 9. pii: 10.1007/s00134-021-06558.
    PubMed     Abstract available


  54. SKURZAK S, Gallo M, Lavezzo B, Iannandrea S, et al
    Goal-directed therapy in sepsis strikes back.
    Intensive Care Med. 2021 Nov 8. pii: 10.1007/s00134-021-06569.
    PubMed    


  55. LATERRE PF, Pickkers P, Marx G, Wittebole X, et al
    Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial.
    Intensive Care Med. 2021;47:1284-1294.
    PubMed     Abstract available


  56. GARBERO E, Livigni S, Ferrari F, Finazzi S, et al
    High dose coupled plasma filtration and adsorption in septic shock patients. Results of the COMPACT-2: a multicentre, adaptive, randomised clinical trial.
    Intensive Care Med. 2021;47:1303-1311.
    PubMed     Abstract available


  57. WENDEL GARCIA PD, Hilty MP, Held U, Kleinert EM, et al
    Cytokine adsorption in severe, refractory septic shock.
    Intensive Care Med. 2021;47:1334-1336.
    PubMed    


    October 2021
  58. STAHL K, Wendel-Garcia PD, Bode C, David S, et al
    Unraveling the secret of re-balancing homeostasis in sepsis: a critical view on extracorporeal blood purification modalities.
    Intensive Care Med. 2021 Oct 28. pii: 10.1007/s00134-021-06560.
    PubMed    


  59. SATO R, Hasegawa D, Dugar S
    Do we have sufficient evidence to support the use of inotropes in patients with sepsis?
    Intensive Care Med. 2021 Oct 26. pii: 10.1007/s00134-021-06564.
    PubMed    


  60. EVANS L, Rhodes A, Alhazzani W, Antonelli M, et al
    Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.
    Intensive Care Med. 2021 Oct 2. pii: 10.1007/s00134-021-06506.
    PubMed    


    September 2021
  61. LIEBCHEN U, Scharf C, Zoller M, Weinelt F, et al
    No clinically relevant removal of meropenem by cytokine adsorber CytoSorb((R)) in critically ill patients with sepsis or septic shock.
    Intensive Care Med. 2021 Sep 14. pii: 10.1007/s00134-021-06487.
    PubMed    


  62. COHEN J, Blumenthal A, Cuellar-Partida G, Evans DM, et al
    The relationship between adrenocortical candidate gene expression and clinical response to hydrocortisone in patients with septic shock.
    Intensive Care Med. 2021;47:974-983.
    PubMed     Abstract available


    August 2021
  63. SWEENEY TE, Wong HR
    Transcriptional markers in response to hydrocortisone in sepsis in ADRENAL: a step toward precision medicine.
    Intensive Care Med. 2021 Aug 10. pii: 10.1007/s00134-021-06504.
    PubMed    


  64. KOSYAKOVSKY LB, Angriman F, Katz E, Adhikari NK, et al
    Association between sepsis survivorship and long-term cardiovascular outcomes in adults: a systematic review and meta-analysis.
    Intensive Care Med. 2021 Aug 9. pii: 10.1007/s00134-021-06479.
    PubMed     Abstract available


    July 2021

  65. Monocyte distribution width as a biomarker of resistance to corticosteroids in patients with sepsis: the MOCORSEP observational study.
    Intensive Care Med. 2021 Jul 27. pii: 10.1007/s00134-021-06478.
    PubMed    



  66. Reducing the global burden of sepsis: a positive legacy for the COVID-19 pandemic?
    Intensive Care Med. 2021;47:733-736.
    PubMed    


    May 2021
  67. LITTON E, Currie A, Raby E
    Probiotics and sepsis: separating the signal from the noise.
    Intensive Care Med. 2021 May 20. pii: 10.1007/s00134-021-06427.
    PubMed    


    March 2021
  68. PELLEGRINI JAS, Schwarz P, Parolo E, Cremonese RV, et al
    All that glitters is not gold: an unusual presentation of S. aureus sepsis during ECMO.
    Intensive Care Med. 2021 Mar 21. pii: 10.1007/s00134-021-06366.
    PubMed    


  69. DAVID S, Bode C, Putensen C, Welte T, et al
    Adjuvant therapeutic plasma exchange in septic shock.
    Intensive Care Med. 2021;47:352-354.
    PubMed    


    February 2021
  70. THOMPSON K, Venkatesh B, Hammond N, Taylor C, et al
    Sex differences in response to adjunctive corticosteroid treatment for patients with septic shock.
    Intensive Care Med. 2021;47:246-248.
    PubMed    


    January 2021
  71. BUETTI N, Ruckly S, de Montmollin E, Reignier J, et al
    COVID-19 increased the risk of ICU-acquired bloodstream infections: a case-cohort study from the multicentric OUTCOMEREA network.
    Intensive Care Med. 2021 Jan 27. pii: 10.1007/s00134-021-06346.
    PubMed     Abstract available


    July 2020
  72. AURIEMMA CL, Delucchi K, Liu KD, Calfee CS, et al
    The attributable mortality of acute respiratory distress syndrome.
    Intensive Care Med. 2020;46:1510-1511.
    PubMed    


  73. DE GROOTH HJ, Tuinman PR, Girbes ARJ
    The attributable mortality of acute respiratory distress syndrome.
    Intensive Care Med. 2020;46:1508-1509.
    PubMed    


    February 2020
  74. TIMSIT JF, Ruppe E, Barbier F, Tabah A, et al
    Bloodstream infections in critically ill patients: an expert statement.
    Intensive Care Med. 2020;46:266-284.
    PubMed     Abstract available


  75. RELLO J, Campogiani L, Eshwara VK
    Understanding resistance in enterococcal infections.
    Intensive Care Med. 2020;46:353-356.
    PubMed    


    January 2020
  76. ROIMI M, Neuberger A, Shrot A, Paul M, et al
    Early diagnosis of bloodstream infections in the intensive care unit using machine-learning algorithms.
    Intensive Care Med. 2020 Jan 7. pii: 10.1007/s00134-019-05876.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Sepsis is free of charge.